These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15036490)

  • 1. Effects of estrogen replacement therapy on natriuretic peptides and blood pressure.
    Karjalainen AH; Ruskoaho H; Vuolteenaho O; Heikkinen JE; Bäckström AC; Savolainen MJ; Kesäniemi YA
    Maturitas; 2004 Mar; 47(3):201-8. PubMed ID: 15036490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J; Sumino H; Ichikawa S; Ozaki M
    Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of long-term transdermal hormone replacement therapy on the renin-angiotensin- aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women.
    Ichikawa A; Sumino H; Ogawa T; Ichikawa S; Nitta K
    Geriatr Gerontol Int; 2008 Dec; 8(4):259-64. PubMed ID: 19149837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of transdermal estrogen therapy on some vasoactive humoral factors and 24-h ambulatory blood pressure in normotensive postmenopausal women.
    Zacharieva S; Atanassova I; Kirilov G; Kalinov K; Shigarminova R; Nachev E; Aslanova N
    Climacteric; 2002 Sep; 5(3):293-9. PubMed ID: 12419088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women.
    Maffei S; Del Ry S; Prontera C; Clerico A
    Clin Sci (Lond); 2001 Nov; 101(5):447-53. PubMed ID: 11672449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen replacement therapy decreases plasma adiponectin but not resistin in postmenopausal women.
    Kunnari A; Santaniemi M; Jokela M; Karjalainen AH; Heikkinen J; Ukkola O; Kesäniemi YA
    Metabolism; 2008 Nov; 57(11):1509-15. PubMed ID: 18940387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma.
    Melander O; von Wowern F; Frandsen E; Burri P; Willsteen G; Aurell M; Hulthén UL
    J Hypertens; 2007 Mar; 25(3):619-27. PubMed ID: 17278979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
    Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women.
    Cacciatore B; Paakkari I; Hasselblatt R; Nieminen MS; Toivonen J; Tikkanen MI; Ylikorkala O
    Am J Obstet Gynecol; 2001 Apr; 184(5):904-9. PubMed ID: 11303197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of early estrogen replacement therapy on microvascular reactivity in patients after bilateral ovarectomy.
    Prázný M; Fait T; Vrablik M
    Neuro Endocrinol Lett; 2007 Aug; 28(4):496-501. PubMed ID: 17693976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ovariectomy and 17beta-estradiol treatment on the renin-angiotensin system, blood pressure, and endothelial ultrastructure.
    Xu X; Xiao JC; Luo LF; Wang S; Zhang JP; Huang JJ; Liu ML; Liu CG; Xu KQ; Li YJ; Song HP
    Int J Cardiol; 2008 Nov; 130(2):196-204. PubMed ID: 18083251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide after hormone therapy in postmenopausal women with chest pain and normal coronary angiogram.
    Kawano H; Nagayoshi Y; Soejima H; Tanaka Y; Hokamaki J; Miyamoto S; Miyazaki Y; Yamabe H; Ogawa H
    Menopause; 2008; 15(2):352-6. PubMed ID: 18090872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial.
    Steiner AZ; Hodis HN; Lobo RA; Shoupe D; Xiang M; Mack WJ
    Menopause; 2005; 12(6):728-33. PubMed ID: 16278616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of low-dose 17beta-estradiol plus dydrogesterone on 24-h ambulatory blood pressure in healthy postmenopausal women: a 1-year, randomized, prospective study.
    Kaya C; Cengiz SD; Cengiz B; Akgun G
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():62-7. PubMed ID: 17943541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
    Balci H; Altunyurt S; Acar B; Fadiloglu M; Kirkali G; Onvural B
    Maturitas; 2005 Apr; 50(4):289-93. PubMed ID: 15780528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral or transdermal hormone replacement therapy on homocysteine levels: a randomized clinical trial.
    Bruschi F; Dal Pino D; Fiore V; Parazzini F; Di Pace R; Cesana BM; Melotti D; Crosignani PG
    Maturitas; 2004 May; 48(1):33-8. PubMed ID: 15223106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
    Oelkers WH
    Climacteric; 2005 Oct; 8 Suppl 3():19-27. PubMed ID: 16203652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of raloxifene therapy on plasma renin and aldosterone levels and blood pressure in postmenopausal women.
    Morgante G; Delia A; Musacchio MC; Severi FM; Petraglia F; De Leo V
    Gynecol Endocrinol; 2006 Jul; 22(7):376-80. PubMed ID: 16864147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-type natriuretic peptide infusions in acute myocardial infarction.
    Hillock RJ; Frampton CM; Yandle TG; Troughton RW; Lainchbury JG; Richards AM
    Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.
    Hoffmann U; Brueckmann M; Bertsch T; Wiessner M; Liebetrau C; Lang S; Haase KK; Borggrefe M; Huhle G
    Clin Lab; 2005; 51(7-8):373-9. PubMed ID: 16122147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.